RECURSION PHARMACEUTICALS, INC. (RXRX) Options Statistics & Positioning

RECURSION PHARMACEUTICALS, INC. (RXRX) options trade at a 30-day at-the-money implied volatility of 120.6%, an IV rank of 41 out of 100 over the past year. The options market prices a ±$1.32 (±37.3%) move in RXRX for the front expiration. Max pain sits at $3 and the put/call open interest ratio is 0.17. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close

$3.55

52-week range

$2.81 – $6.80

ATM IV (30d)

120.6%

IV rank

41 / 100

Moderate

Expected move

±$1.32 (±37.3%)

Put/call OI

0.17

Call-heavy

Max pain

↓ 15.4% below close

Next earnings

Aug 9, 2026

Most Active RXRX Contracts

Contract	Expiration	DTE	Last	IV	Volume
RXRX $4 call	Jul 17, 2026	7d	$0.06	90.9%	1,714
RXRX $3.5 call	Jul 17, 2026	7d	$0.19	82.1%	864
RXRX $3.5 put	Jul 17, 2026	7d	$0.11	83.4%	593
RXRX $20 call	Jan 15, 2027	189d	$0.10	133.9%	479
RXRX $4.5 call	Jul 24, 2026	14d	$0.04	91.6%	307

See all active RXRX contracts →

Explore RXRX Options Statistics

RXRX Implied Volatility

120.6% ATM IV (30d)

An IV rank of 41 places implied volatility in the middle of its 52-week range.

Full implied volatility analysis →

RXRX Open Interest

0.17 put/call OI ratio

315,388 calls and 54,822 puts outstanding across all expirations.

Full open interest analysis →

RXRX Max Pain

$3 max pain

15.4% below the last close — see how max pain has moved over the past year.

Full max pain analysis →

RXRX Gamma Exposure

$48.67M net GEX

Positive dealer gamma — hedging currently leans against price swings.

Full gamma exposure analysis →

RXRX Options Volume

11,904 contracts traded

Put/call volume ratio 0.12 — plus contracts running far above their usual volume.

Full volume & flow analysis →

RXRX Most Active Options

$3.5 top volume strike

The 25 most actively traded RXRX contracts with price, IV, greeks, and volume vs. average.

Full active contracts analysis →

Upcoming Earnings

RXRX's next expected earnings date is Aug 9, 2026. Options currently price a ±$1.32 (±37.3%) move for the front expiration.

Explore the payoff profile of option on RXRX for free

Build multi-leg RXRX strategies, visualize payoffs, and scan the full US options universe with OptiView.

Open RXRX in the platform Scan options

RXRX Options FAQ

When is RXRX's next earnings date?

RXRX's next expected earnings date is Aug 9, 2026. Options currently price a ±$1.32 (±37.3%) move for the front expiration.

How often is RXRX options data on this page updated?

All RXRX statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see RXRX max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated RXRX pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.